392 related articles for article (PubMed ID: 18280763)
21. A Bayesian approach for sample size determination in method comparison studies.
Yin K; Choudhary PK; Varghese D; Goodman SR
Stat Med; 2008 Jun; 27(13):2273-89. PubMed ID: 17979182
[TBL] [Abstract][Full Text] [Related]
22. Confidence in polymerase chain reaction diagnosis can be improved by Bayesian estimation of post-test disease probability.
Kelly P; Pereira-Maxwell F; Carnaby S; White I
J Clin Epidemiol; 2005 Mar; 58(3):252-60. PubMed ID: 15718114
[TBL] [Abstract][Full Text] [Related]
23. Assessment of small health risks based on exact sample sizes.
Abt K; Gülich A
Stat Med; 1996 Jan; 15(2):183-95. PubMed ID: 8614754
[TBL] [Abstract][Full Text] [Related]
24. A tutorial on a practical Bayesian alternative to null-hypothesis significance testing.
Masson ME
Behav Res Methods; 2011 Sep; 43(3):679-90. PubMed ID: 21302025
[TBL] [Abstract][Full Text] [Related]
25. Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.
Diamond GA; Kaul S
J Am Coll Cardiol; 2004 Jun; 43(11):1929-39. PubMed ID: 15172393
[TBL] [Abstract][Full Text] [Related]
26. [Bayesian statistics in medicine. Part I: The basic tools].
Nichelatti M; Montomoli C
G Ital Nefrol; 2008; 25(3):342-6. PubMed ID: 18473305
[TBL] [Abstract][Full Text] [Related]
27. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
28. A Bayesian predictive two-stage design for phase II clinical trials.
Sambucini V
Stat Med; 2008 Apr; 27(8):1199-224. PubMed ID: 17763528
[TBL] [Abstract][Full Text] [Related]
29. Nonparametric confidence intervals for Tmax in sequence-stratified crossover studies.
Willavize SA; Morgenthien EA
Pharm Stat; 2008; 7(1):9-19. PubMed ID: 17256803
[TBL] [Abstract][Full Text] [Related]
30. Probability fold change: a robust computational approach for identifying differentially expressed gene lists.
Deng X; Xu J; Hui J; Wang C
Comput Methods Programs Biomed; 2009 Feb; 93(2):124-39. PubMed ID: 18842321
[TBL] [Abstract][Full Text] [Related]
31. A predictive Bayesian approach to the design and analysis of bridging studies.
Gould AL; Jin T; Zhang LX; Wang WW
J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
[TBL] [Abstract][Full Text] [Related]
32. The Bayesian interpretation of a P-value depends only weakly on statistical power in realistic situations.
Hooper R
J Clin Epidemiol; 2009 Dec; 62(12):1242-7. PubMed ID: 19398295
[TBL] [Abstract][Full Text] [Related]
33. Bayesian evaluation of inequality and equality constrained hypotheses for contingency tables.
Klugkist I; Laudy O; Hoijtink H
Psychol Methods; 2010 Sep; 15(3):281-99. PubMed ID: 20822253
[TBL] [Abstract][Full Text] [Related]
34. On the estimation of the binomial probability in multistage clinical trials.
Jung SH; Kim KM
Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
[TBL] [Abstract][Full Text] [Related]
35. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
36. A Bayesian non-inferiority test for two independent binomial proportions.
Kawasaki Y; Miyaoka E
Pharm Stat; 2013; 12(4):201-6. PubMed ID: 23625633
[TBL] [Abstract][Full Text] [Related]
37. Statistical significance--a misconstrued notion in medical research.
Nurminen M
Scand J Work Environ Health; 1997 Jun; 23(3):232-5. PubMed ID: 9243735
[TBL] [Abstract][Full Text] [Related]
38. On estimating the difference between two probabilities, with special reference to clinical trials.
Anbar D
Biometrics; 1983 Mar; 39(1):257-62. PubMed ID: 6871355
[TBL] [Abstract][Full Text] [Related]
39. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
Liu C; Shen W; Xie J
Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
[TBL] [Abstract][Full Text] [Related]
40. Calculating the main alternatives to null-hypothesis-significance testing in between-subject experimental designs.
Balluerka Lasa N; Vergara Iraeta AI; Arnau Gras J
Psicothema; 2009 Feb; 21(1):141-51. PubMed ID: 19178869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
